ATE123941T1 - Verwendung von aminosäuren zum schutz von ischemischem herzgewebe und dessen metabolischer wiederherstellung. - Google Patents

Verwendung von aminosäuren zum schutz von ischemischem herzgewebe und dessen metabolischer wiederherstellung.

Info

Publication number
ATE123941T1
ATE123941T1 AT91117799T AT91117799T ATE123941T1 AT E123941 T1 ATE123941 T1 AT E123941T1 AT 91117799 T AT91117799 T AT 91117799T AT 91117799 T AT91117799 T AT 91117799T AT E123941 T1 ATE123941 T1 AT E123941T1
Authority
AT
Austria
Prior art keywords
amino acids
protection
heart tissue
ischemic heart
restoration
Prior art date
Application number
AT91117799T
Other languages
English (en)
Inventor
David Madsen
Gary Pace
Bruce Rowe
Original Assignee
Clintec Nutrition Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24423981&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE123941(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Clintec Nutrition Co filed Critical Clintec Nutrition Co
Application granted granted Critical
Publication of ATE123941T1 publication Critical patent/ATE123941T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
AT91117799T 1990-10-30 1991-10-18 Verwendung von aminosäuren zum schutz von ischemischem herzgewebe und dessen metabolischer wiederherstellung. ATE123941T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60551490A 1990-10-30 1990-10-30

Publications (1)

Publication Number Publication Date
ATE123941T1 true ATE123941T1 (de) 1995-07-15

Family

ID=24423981

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91117799T ATE123941T1 (de) 1990-10-30 1991-10-18 Verwendung von aminosäuren zum schutz von ischemischem herzgewebe und dessen metabolischer wiederherstellung.

Country Status (9)

Country Link
EP (1) EP0483614B1 (de)
JP (1) JPH04264024A (de)
AT (1) ATE123941T1 (de)
AU (1) AU655780B2 (de)
CA (1) CA2054134A1 (de)
DE (1) DE69110615T2 (de)
DK (1) DK0483614T3 (de)
ES (1) ES2074623T3 (de)
GR (1) GR3017321T3 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5852058A (en) * 1993-06-11 1998-12-22 The Board Of Trustees Of The Leland Stanford Junior University Intramural delivery of nitric oxide enhancer for inhibiting lesion formation after vascular injury
US5891459A (en) 1993-06-11 1999-04-06 The Board Of Trustees Of The Leland Stanford Junior University Enhancement of vascular function by modulation of endogenous nitric oxide production or activity
DE69637676D1 (de) * 1995-11-09 2008-10-23 Univ R Verwendung von lokal verabreichten Lysine zur VERBESSERUNG DER VASKULAREN FUNKTION
US6127419A (en) * 1998-11-23 2000-10-03 Burzynski; Stanislaw R. Phenylacetic acid compositions for treating or preventing atherosclerosis and restenosis
IT1320782B1 (it) 2000-07-04 2003-12-10 Professional Dietetics Srl Composizioni a base di aminoacidi, atte al trattamentodell'insufficienza cardiaca.
CA2425773A1 (en) * 2000-10-13 2003-04-11 Chugai Seiyaku Kabushiki Kaisha Compositions for improving lipid metabolism
ITTO20010580A1 (it) * 2001-06-15 2002-12-15 Professional Dietetics Srl Composizioni a base di aminoacidi per il miglioramento della funzioneventricolare miocardica in pazienti affetti da diabete.
JP2008056566A (ja) * 2004-12-28 2008-03-13 Toudai Tlo Ltd 低酸素応答促進剤
JP2018522950A (ja) * 2015-08-11 2018-08-16 杉山　理 血液循環の改善及びミトコンドリアエネルギー産生の維持のためのシステム並びに方法
JP6838752B2 (ja) * 2019-08-30 2021-03-03 株式会社東洋新薬 血流改善組成物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3228127A1 (de) * 1982-07-28 1984-02-02 Basf Ag, 6700 Ludwigshafen Aminosaeuren-infusionsloesungen
AU8033487A (en) * 1986-09-10 1988-04-07 Dudrick Medical Research Fund I. Ltd. Method and substrate composition for treating atherosclerosis

Also Published As

Publication number Publication date
EP0483614A1 (de) 1992-05-06
ES2074623T3 (es) 1995-09-16
DE69110615T2 (de) 1995-12-14
GR3017321T3 (en) 1995-12-31
AU8567091A (en) 1992-05-07
DE69110615D1 (de) 1995-07-27
AU655780B2 (en) 1995-01-12
JPH04264024A (ja) 1992-09-18
EP0483614B1 (de) 1995-06-21
CA2054134A1 (en) 1992-05-01
DK0483614T3 (da) 1995-10-30

Similar Documents

Publication Publication Date Title
SE8703625D0 (sv) New medical use
DK1316308T3 (da) Transdermalt terapeutisk plaster med capsaicin og capsaicin-analoger
DE69534468D1 (de) Wachstums-differenzierungsfaktor-11
GEP20012413B (en) Novel Substituted Cyclic Amino Acids as Pharmaceutical Agents
ATE76294T1 (de) Galanthamin oder dessen analoge zur behandlung der alzheimerschen krankheit.
DE3752045D1 (de) Verwendung von Hydroxycarbonsäuren und Derivaten zur Herstellung topischer dermatologischer Zubereitungen zur Behandlung von Falten
EP0336880A3 (de) Verwendung von topisch applizierbaren Präparaten zur Behandlung der Altershaut
DE3684190D1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
IE791235L (en) Acyl-derivatives of carnitine.
DE69110615D1 (de) Verwendung von Aminosäuren zum Schutz von ischemischem Herzgewebe und dessen metabolischer Wiederherstellung.
DE69327328D1 (de) Verwendund von norastemizol zur behandlung der allergischen rhinitis
ATE220923T1 (de) Rekombinante adenoviren und deren verwendung in der gentherapie zur behandlung von augenerkrankungen
ATE84716T1 (de) 4-chinolincarbonsaeure-derivate, brauchbar zur behandlung von haut- und muco-epithelialgewebekrankheiten.
NO995944D0 (no) Anti-arrytmisk blanding og fremgangsmåter for behandling
EP0199117A3 (de) Therapeutische Verwendung von Phosphokreatin
ZA87466B (en) Heptanoyl-glu-asp-ala-amino acid immunostimulants
ATE45675T1 (de) Verwendung von interferon gamma (ifn-gamma) zur herstellung von praeparationen zur behandlung rheumatischer erkrankungen.
DE69725312D1 (de) Verbesserte elektrophoretische verabreichung von therapeutischen wirkstoffen mit polybasischen anionischen gegenionen
RU96122371A (ru) Способ лечения эндогенных и послеоперационных увеитов
ATE74755T1 (de) Verwendung von n-(1-allyl-2-pyrrolidinylmethyl)-2-methoxy-4-am no-5-methylsulfamoylbenzamid zur behandlung der parkinson-krankheit.
ATE88090T1 (de) Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom.
DE3786442D1 (de) Verwendung von follikelreifungshormon zur herstellung eines therapeutischen mittels zur behandlung von neoplasmen von gonadalem ursprung.
AP8500009A0 (en) New phenoxypropanolamine salts and pharmaceutical preparations thereof.
DE68906028D1 (de) Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
RZN Patent revoked